.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Teva
Queensland Health
Cantor Fitzgerald
QuintilesIMS
Chinese Patent Office
Colorcon
McKinsey
Farmers Insurance
UBS

Generated: September 19, 2017

DrugPatentWatch Database Preview

E-MYCIN E Drug Profile

« Back to Dashboard

What is the patent landscape for E-mycin E, and what generic E-mycin E alternatives are available?

E-mycin E is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in E-MYCIN E is erythromycin ethylsuccinate. There are ninety-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

Summary for Tradename: E-MYCIN E

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list22
Patent Applications: see list548
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:E-MYCIN E at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
E-MYCIN E
erythromycin ethylsuccinate
SUSPENSION;ORAL062198-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
E-MYCIN E
erythromycin ethylsuccinate
SUSPENSION;ORAL062198-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Deloitte
Covington
Medtronic
Queensland Health
McKinsey
Chinese Patent Office
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot